Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 8.28
-0.03 (-0.36%)
Nov 3, 2025, 2:37 PM CET
Mabion Company Description
Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
It offers drug substance manufacturing, fill and finish, gene to vial: end-to-end development, process development, analytics, and cell line development and banking services.
The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
Mabion S.A.
| Country | Poland |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 213 |
| CEO | Krzysztof Kaczmarczyk |
Contact Details
Address: Medical Biotechnology Scientific and Industrial Complex Konstantynów Lódzki, 95-050 Poland | |
| Phone | 48 42 207 7890 |
| Website | mabion.eu |
Stock Details
| Ticker Symbol | MAB |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMBION00016 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Krzysztof Kaczmarczyk | Chief Executive Officer and President of Management Board |
| Grzegorz Grabowicz | Chief Financial Officer and Financial Director |
| Adam Pietruszkiewicz | Chief Commercial Officer, Business Development Director and Member of Management Board |
| Julita Balcerek M.D. | Member of the Management Board, Operations Director and Chief Operating Officer |
| Pawel Pobiedzinski | Head of Logistics and Procurement |
| Joanna Krolasik | Head of Microbiology Laboratory |